December 16, 2021

Last week, the Goldwater Institute signed on to a coalition letter led by the National Taxpayers Union in opposition to Democrats’ big government socialism plan that would hinder “drug and biological development, as well as the availability of generics and biosimilars in both Medicare and the private health insurance marketplace.”

The Goldwater Institute has long been a leader in opposing arbitrary, top-down government mandates on American healthcare, which pose an immediate danger to both the quality of care for all patients and to the future of treatment innovations. 

This proposal from Congress would impose price controls and an inflationary rebate penalty on every medicine, an arbitrary policy that could create an incentive for manufacturers to automatically increase the list price of their drugs each year to keep pace with inflation. 

Rather than promote healthcare access and affordability, this proposal would harm competition and access to cures, crush medical innovation, upend the market-based structure of Medicare Part D, and cost high-paying American jobs. The letter urges members of Congress to oppose this dangerous plan.

You can read the full coalition letter here, and learn more about Goldwater’s plan to put patients first by unleashing innovation in healthcare here.

Print Friendly, PDF & Email